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Chinese mainlandally screened the polymorphisms of the whole CYP2D6 gene in the populations of
four different geographical locations in China, namely, Shanghai, Shantou, Shenyang, and Xi'an, using a
sample of 100 subjects from each population. Forty-eight different polymorphisms were detected as well as
12 novel ones. One novel nonsynonymous SNP was detected, and one novel intronic SNP was revealed that
might inactivate a cryptic donor site 392 nucleotides downstream of the exon 6 natural donor site. In
addition, the frequencies of some polymorphisms and alleles demonstrated signiﬁcant differences among the
four populations. Linkage disequilibrium analysis and tag SNP selection were performed separately for each
population. Haplotypes were analyzed within the selected tag SNPs. Tag SNP selection and haplotype
distributions showed differences across the four populations. This is the ﬁrst large-scale study to analyze
polymorphisms systematically across the whole CYP2D6 gene in the Chinese Han population.
© 2008 Elsevier Inc. All rights reserved.It is well known that much of the observed variation in drug
efﬁcacy and safety has a hereditary basis, arising from polymorphisms
in drug-metabolizing enzyme (DME) genes. The CYP2D6 gene, located
on chromosome 22q13.2, codes for a major drug-metabolizing
enzyme that plays a central role in the biotransformation of a large
number of commonly prescribed drugs, including many antidepres-
sants, antipsychotics, β-adrenergic blocking agents, antihyperten-
sives, antiarrhythmics, and opioids [1]. The CYP2D6 gene locus is
highly polymorphic, and more than 75 different alleles have been
described to date. The polymorphism of the enzyme results in poor
metabolizers, intermediate metabolizers, extensive metabolizers, and
ultraextensive metabolizers of CYP2D6 drugs [2]. Abnormal CYP2D6
activity can result in adverse drug effects and therapeutic failure, so
CYP2D6 genotyping could become a routine part of an individualized
drug treatment.
The frequency of DME alleles can vary greatly between populations
of different ethnic or geographic origins [3,4]. CYP2D6⁎3, CYP2D6⁎4,
and CYP2D6⁎5, which result in loss of CYP2D6 function, occur at
frequencies of 20, 2–7, and 1–2%, respectively, in Caucasian popula-
tions [5]. However, these alleles are rare among most Asian and Black
African populations [5]. The CYP2D6⁎10 allele, which result in a P34S
substitution (C188T) and produces a low-activity enzyme, has al rights reserved.frequency as high as 45% in the Korean population [6] and 38.1% in the
Japanese population [7], whereas it has a low frequency (1.5%) in
Caucasians [8]. CYP2D6 gene duplications, many of which lead to the
ultrarapidmetabolizer phenotype, have been found in 20 to 30% of the
populations of Ethiopia and Saudi Arabia [9,10]. However, in other
African countries like Ghana, Zimbabwe, and Tanzania, this frequency
is much lower, at 2–8%. In addition, very few subjects with gene
duplications are detected in Asia and Northern Europe [11].
There have been only a few studies on the polymorphisms of
CYP2D6 in the Chinese Han population, and even these have examined
only small populations and have been focused on just a few known
alleles [12,13]. As the largest population (nearly 20%) in the world, the
Chinese Han population is spread over the third largest populated area
with a landmass of about 9.6million km2. In addition, the Han have an
extremely long and complex demographic history (starting from the
ancient Huaxia tribe in the 21st–8th centuries BC, which then
integrated with numerous tribes and ethnic groups), and the popula-
tion stratiﬁcation arising from the interplay of different geographic
areas will therefore have inﬂuenced the polymorphism pattern. A
previous study by our group found that a cryptic borderline was
observable between the Southern Han and the Northern Han samples
[14]. No polymorphism study of the CYP2D6 gene focusing on the
different geographic Han populations has been carried out to date.
Moreover, speciﬁc haplotypes and allele combinations rather than
single polymorphisms may provide a better basis for individualizing
treatment. However, no systematic polymorphism screening or linkage
153S. Qin et al. / Genomics 92 (2008) 152–158disequilibrium (LD) pattern and haplotype analysis of the whole
CYP2D6 gene has been conducted in the Han or other population.
To build a database of CYP2D6 allele frequencies for a normal
Chinese Han population, which would be useful for optimizing
pharmacotherapy with CYP2D6-substrate drugs, we aimed to screen
systematically the polymorphisms of the whole CYP2D6 gene,
including the 5′ ﬂanking region, all exons, and all introns, in the
four different geographic Chinese Han populations covering the north,
south, west, and east of the Chinese mainland. We also investigated
the LD pattern and haplotype construction of this gene in these
populations.
Results
In the mainland Chinese Han population, a total of 48 different
genetic polymorphisms were detected in the CYP2D6 gene. The alleleTable 1
The positions and frequencies of CYP2D6 polymorphisms in the Chinese population
Positiona Reference Region Effectb
Sha
(n=
−2182 rs28360521 5′-UTR Not translated G(A) 48.4
−2065 rs28439297 5′-UTR Not translated A(G) 31.9
−2057 rs28680494 5′-UTR Not translated G(T) 32.8
−1775 rs1080983 5′-UTR Not translated A(G) 16.5
−1589 rs1080985 5′-UTR Not translated G(C) 12.2
−1431 rs28588594 5′-UTR Not translated C(T) 48.3
−1235 rs1080988 5′-UTR Not translated T(C) 32.7
−1000 rs1080989 5′-UTR Not translated G(A) 45.3
−741 Novel 5′-UTR Not translated T(C) 14.5
−678 rs28633410 5′-UTR Not translated A(G) 13.8
−528 Novel 5′-UTR Not translated T(C) 0.6
−498 Novel 5′-UTR Not translated A(C) 12.3
−345 Novel 5′-UTR Not translated C(T) 0
−336 Novel 5′-UTR Not translated G(A) 0
100 rs1065852 Exon 1 S34P G(A) 48.3
213 rs1080995 Intron 1 Not translated C(G) 12.8
220 rs1080996 Intron 1 Not translated T(G) 12.8
222 rs1080997 Intron 1 Not translated G(C) 12.2
226 rs1080998 Intron 1 Not translated G(A) 13.8
231 rs1080999 Intron 1 Not translated C(G) 12.8
232 rs28695233 Intron 1 Not translated G(T) 12.8
244 rs1081000 Intron 1 Not translated C(T) 10.5
309 rs28371699 Intron 1 Not translated C(A) 17.7
745 rs28371701 Intron 1 Not translated G(C) 15.1
842 rs28371702 Intron 1 Not translated T(G) 33.3
1038 rs1081003 Exon 2 Silent mutation C(T) 48.4
1759 rs5030865 Intron 3 Not translated T(C) 0
1784 Novel Intron 3 Not translated G(T) 0
1791 Novel Intron 3 Not translated C(T) 0.6
1837 Novel Intron 3 Not translated A(G) 2.2
1847 rs1800716 Intron 3 Not translated T(C) 0
2098 rs2267447 Intron 4 Not translated T(C) 47.3
2304 rs28371715 Intron 4 Not translated A(G) 2.2
2467 rs17002853 Exon 5 P231L G(A) 5.7
2664 rs28371722 Intron 5 Not translated T(C) 7.4
2851 rs16947 Exon 6 R296C T(C) 17.4
2989 rs28371725 Intron 6 Not translated A(G) 6.5
3385 rs1985842 Intron 7 Not translated A(C) 32.4
3583 rs2004511 Intron 7 Not translated A(G) 45.3
3585 rs28371730 Intron 7 Not translated A(G) 14.2
3739 Novel Intron 7 Not translated G(A) 0
3791 rs28371731 Intron 7 Not translated A(G) 14.4
4028 Novel Intron 8 Not translated A(G) 0
4046 Novel Exon 9 R441H T(C) 0.5
4181 rs1135840 Exon 9 S486T G(C) 30.9
4402 rs28371738 3′-UTR Not translated C(T) 46.4
4445 Novel 3′-UTR Not translated G(A) 1.4
4482 rs28572577 3′-UTR Not translated A(G) 13.2
a The position in the gene is according to the reference sequence AY545216 in GenBank,
b The accession number for the protein reference sequence is P10635.
c The P value is for the comparison of the polymorphism frequencies among the four diffand genotype frequencies, which were analyzed using the Arlequin
program,were in equilibriumwith theHardy-Weinberg equation. In the
5′ ﬂanking region, 14 polymorphisms were detected, including 5 novel
ones. The Tfsitescan analysis showed that no novel polymorphisms
altered transcription factor binding efﬁciency. In the coding region, 6
polymorphisms were detected, including 1 novel nonsynonymous
SNP (g.4046G→A, p.441R→H). Of these polymorphisms, 5 were non-
synonymous SNPs, and 1 was synonymous. In addition, we detected
28 polymorphisms in the introns, 6 of which were novel. Through
information theory-based splice-site analysis, the g.3739T→C SNP in
intron 7 revealed a change in Ri value of a cryptic donor site, located
392 nucleotides downstream of the exon 6 natural donor site, from
0.9 to –6.6 bits. We also compared all the polymorphism frequencies
in the four different geographic populations by statistical analysis.
According to the statistical comparison, 10 SNPs (20.83% of the total
48 SNPs) had a P value of less than 0.0001 and 18 SNPs (37.5% of theMinor allele frequency (%)
nghai Xi'an Shenyang Shantou Chinese P valuec
100) (n=100) (n=100) (n=100) (n=400)
28.6 43.4 19.9 35.08 b0.0001
25.3 28 10.6 23.95 b0.0001
25.7 28 10.6 24.28 b0.0001
12.3 17.3 3.5 12.4 b0.0001
8.9 13.8 1.7 9.15 b0.0001
42.1 51.7 34.2 44.08 0.0021
24.4 28.2 16.7 25.5 0.0023
41.5 36.8 37.2 40.2 0.2428
11.1 13.3 14.4 13.33 0.7024
12.6 15.1 15.4 14.23 0.8352
0 0 0 0.15 0.3910
10.6 7.9 8.4 9.8 0.4151
0 0.6 0.6 0.3 0.5714
0 0 0.6 0.15 0.3910
44.3 47.8 33.9 43.58 0.0113
11.2 5.3 12.2 10.38 0.0645
11.2 5.3 12.2 10.38 0.0645
11.2 5.3 12.2 10.23 0.0931
11.2 5.3 12.2 10.63 0.0392
11.2 4.8 12.2 10.25 0.0380
11.2 5.3 12.2 10.38 0.0645
11.2 5.3 11.7 9.68 0.1491
24.7 28.1 12.6 20.78 0.0005
11.3 17 13.6 14.25 0.4471
29.9 23.9 8.2 23.83 b0.0001
40.7 46.7 28.8 41.15 0.0003
2.2 1.1 1.7 1.25 0.0048
0.5 0 0 0.13 0.2500
0.5 1.3 1.1 0.88 0.0258
0.5 0.7 1.1 1.13 0.0128
0 0.7 0 0.18 0.2500
41.8 50.5 34.8 43.6 0.0101
1 3.1 0.5 1.7 0.0027
0 0.5 4.9 2.78 0.0003
4.7 5 1.3 4.6 0.0412
12.6 21.1 14.3 16.35 0.1109
1.1 3.9 2 3.38 0.0126
29.9 22 16 25.08 0.0004
45.5 14 7.9 28.18 b0.0001
10.9 4.5 2.2 7.95 b0.0001
0 0 0.5 0.13 0.2500
11.7 19.3 16.5 15.48 0.1583
0 0 1.1 0.28 0.0623
0 0 0 0.13 0.2500
34.6 32 22.2 29.93 0.0365
49.4 69.5 60.9 56.55 b0.0001
0 0 3.1 1.13 b0.0001
14.5 25.8 14.6 17.03 0.0014
and the A of the ATG translation initiation codon is denoted nucleotide+1.
erent geographic populations.
Table 2
CYP2D6 allele frequencies in four different geographical Chinese populations
CYP2D6 allele Allele frequency (%)
Shanghai
(n=100)
Xi'an
(n=100)
Shenyang
(n=100)
Shantou
(n=100)
Chinese
(n=400)
P valuea
⁎1 30.23 25.68 24.72 17.95 24.65 0.0471
⁎2 9.3 10.87 15.73 8.33 11.06 0.1216
⁎3 0 0 0 0 0
⁎4 0 0 0.56 0 0.14 0.2500
⁎5 4.07 7.06 3.67 3.85 4.66 0.3226
⁎6 0 0 0 0 0
⁎7 0 0 0 0 0
⁎8 0 0 0 0 0
⁎9 0 0 0 0 0
⁎10 48.84 50.54 46.63 64.1 52.53 0.0020
⁎11 0 0 0 0 0
⁎12 0 0 0 0 0
⁎13 0 0 0 0 0
⁎14 0 1.63 1.12 2.56 1.33 0.0024
⁎15 0 0 0 0 0
⁎16 0 0 0 0 0
⁎17 0 0 0 0 0
⁎18 0 0 0 0 0
⁎21 0 0 0 0 0
⁎27 0 0 0 0 0
⁎35 0 0 0 0 0
⁎39 0 0 0 0 0
⁎41 6.4 1.08 3.93 1.93 3.34 0.0126
⁎47 0 0 0 0 0
Duplication 0.58 1.63 2.24 1.28 1.43 0.0111
⁎1×N 0.58 1.63 0 0 0.55 0.0155
⁎2 × N 0 0 1.12 0.64 0.44 0.0468
⁎10×N 0 0 1.12 0.64 0.44 0.0468
a The P value is for the comparison of the allele frequencies among the four different
geographic populations.
Table 3
CYP2D6 genotypes in four different geographical Chinese populations
CYP2D6 genotype Frequency (%)
Shanghai
(n=100)
Xi'an
(n=100)
Shenyang
(n=100)
Shantou
(n=100)
Chinese
(n=400)
P valuea
⁎1/⁎1 8.14 5.43 7.87 5.13 6.64 0.6867
⁎1/⁎2 5.82 6.52 5.62 2.56 5.13 0.6299
⁎1/⁎5 3.49 2.17 0 0 1.41 0.0096
⁎1/⁎10 32.57 30.43 28.09 21.8 28.22 0.3626
⁎1/⁎14 0 0 0 0 0
⁎1/⁎41 1.16 1.09 0 1.28 0.88 0.0945
⁎2/⁎2 2.33 2.18 3.38 2.56 2.61 0.0248
⁎2/⁎4 0 0 1.12 0 0.28 0.2500
⁎2/⁎5 0 0 1.12 0 0.28 0.2500
⁎2/⁎10 6.98 8.7 13.48 7.69 9.21 0.4804
⁎2/⁎14 0 0 1.12 0 0.28 0.2500
⁎2/⁎41 1.16 0 3.38 1.28 1.45 0.0194
⁎5/⁎5 0 0 0 0 0
⁎5/⁎10 3.49 8.7 2.25 7.69 5.53 0.0682
⁎5/⁎41 1.16 0 0 0 0.29 0.2500
⁎10/⁎10 23.26 23.91 20.22 43.59 27.75 0.0004
⁎10/⁎14 0 2.18 1.12 2.56 1.46 0.0146
⁎10/⁎41 6.98 1.09 4.49 1.28 3.46 b0.0001
⁎14/⁎14 0 1.09 0 0 0.27 0.2500
⁎41/⁎41 1.16 0 0 0 0.29 0.2500
⁎1×N/⁎1 1.16 0 0 0 0.29 0.2500
⁎1×N/⁎2 0 0 0 1.29 0.32 0.2500
⁎1×N/⁎10 0 3.26 0 0 0.82 0.0153
⁎2×N/⁎2 0 0 1.12 0 0.28 0.2500
⁎2×N/⁎10 0 0 1.12 0 0.28 0.2500
⁎10×N/⁎10 0 0 2.25 1.29 0.89 0.0468
a The P value is for the comparison of the genotype frequencies among the four
different geographic populations.
154 S. Qin et al. / Genomics 92 (2008) 152–158total 48 SNPs) had a P value ranging from 0.0001 to 0.05, which
indicated signiﬁcant differences among the four populations. All of
the polymorphisms found in this study and their minor allele
frequencies are summarized in Table 1.
The identiﬁcation of the CYP2D6 alleles and genotypes was based
on the polymorphisms found in the present study. Ten different
CYP2D6 alleles and 26 genotypes were detected. In the mainland
Chinese Han population, the most frequent alleles were ⁎10 (52.53%)
and the wild-type allele ⁎1 (24.65%). We also compared the
frequencies of the alleles and genotypes across the four populations
by statistical analysis. Seven allele and eight genotype distributions
demonstrated signiﬁcant differences. All the results are shown in
Tables 2 and 3.
Linkage disequilibrium between each pair of SNPs was calculated
for each of the four populations through Haploview analysis. The
results are shown in Fig. 1. The observed results suggested the
existence of high levels of LD over some genomic region spanning the
CYP2D6 gene. Also, the levels of linkage disequilibrium were different
in the four geographical populations. Through Haploview analysis, the
tag polymorphisms were selected separately in the four geographical
populations. The haplotypes were constructed from the tag SNPs in
each population. The tag SNP selection and haplotype frequencies in
the four different geographical populations are summarized in Table 4.
The results showed that each geographical population had different
tag SNP selection and haplotype distribution for CYP2D6. Also, each
geographical population had one dominant haplotype with a
frequency higher than 35%.
The allele and genotype frequencies observedwere comparedwith
those of other major populations such as Korean, Caucasian, African
American, Japanese, and Spanish. As shown in Table 5, the ⁎10 allele
occurred at a notably higher frequency in Chinese (52.53%) than in
Caucasians (1.53%) and at a slight higher frequency than in Koreans
(45%) [6,8]. Although other functionally inactive alleles (CYP2D6⁎3, ⁎6,
⁎7, and ⁎15) have been described in Caucasian populations [8], theywere not detected in any of the subjects in this study. Alleles
CYP2D6⁎21, ⁎27, ⁎35, ⁎39, and ⁎47 [6], which had been found in the
Korean population, were not detected in our study.
Discussion
CYP2D6, which makes up only 1.5% of the total cytochrome P450
isoforms, metabolizes up to one-quarter of all prescribed drugs.
Assessment of CYP2D6 metabolic status before initiation of therapy
may help to identify patients at risk for nonresponse to therapy or
toxic drug effects and is needed to ensure optimal dosing recommen-
dations [15,16]. In addition, such assessment should improve patient
outcome by reducing adverse drug reactions and improving drug
efﬁcacy. CYP2D6 alleles associated with metabolizer phenotypes are
the result of various point mutations. It is already known that
polymorphism frequencies occur with varying prevalence in popula-
tions of different ethnic or geographic origins. Therefore, it is essential
to conduct a polymorphism analysis in various populations. Few
studies have focused on the Chinese Han population to date. To the
best of our knowledge, this is the ﬁrst study to conduct systematic
polymorphism analysis of the whole CYP2D6 gene among different
geographic Han populations of the Chinese mainland.
In this study, one novel nonsynonymous SNP, which could result in
the change of Arg to His, was identiﬁed for the ﬁrst time in the Chinese
Han population. In addition, we found the novel intronic SNP
g.3739T→C, which might inactivate a cryptic donor site of exon 6,
through information theory-based analysis, a tool that has been
successfully used to predict the splicing site in CYP genes [17,18]. Based
on the polymorphisms we found, we identiﬁed the prevalent alleles
(CYP2D6⁎10, ⁎1) and the most common inactive alleles (CYP2D6⁎4, ⁎5,
⁎14) in the Chinese Han population, ﬁndings that are consistent with
previous reports [12]. Some allele and genotype frequencies demon-
strated differences among the four different geographic populations,
which are subgroups of the overall Chinese Han population. Each
subgroup differs from the others in its diet, cultural habits, and
Fig.1. Pairwise linkage disequilibrium of the SNPs in the CYP2D6 gene in the four geographical Chinese populations of (A) Shanghai, (B) Shantou, (C) Shenyang, and (D) Xi'an. An r2 color scheme is used to display LDwith black for very strong LD
(r2=1), white for no LD (r2=0), and shades of gray for intermediate LD (0br2b1).
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Table 4
The tag SNPs and haplotypes of the CYP2D6 gene in four different geographical Chinese
populations
Region Tag SNPs Haplotypesa Frequency (%)
Shanghai g.-2182G→A; g.-498A→C; g.100G→A; ACATACGCCCGG 40.00
g.244C→T; g.309C→A; g.745G→C; GAGTACTTCAAG 9.80
g.842T→G; g.2098T→C; g.2851T→C; GCGTACTTCAAG 6.70
g.3385A→C; g.3583A→G; g.3585A→G GCGTAGGTTCAA 6.20
GCGTCCTTCAAG 5.70
GCGCAGGTTCAA 3.90
ACATCCGCCCGG 3.10
Shantou g.-2065A→G; g.-1431C→T; g.-
1000G→A;
GATGCACGCCCGG 44.20
g.-678A→G; g.213C→G; g.309C→A; GACGCACGCCCGG 3.60
g.745G→C; g.842T→G; g.2098T→C; GGCAGAGGTTCAA 3.60
g.2851T→C; g.3385A→C; g.3791A→G;
g.4482A→G
Shenyang g.-2065A→G; g.-1775A→G; g.-
1431C→T;
GGATGGAAGTCC 35.40
g.-1000G→A; g.-741T→C; g.-678A→G; AGGCGGGCTCTC 12.30
g.100G→A; g.309C→A; g.842T→G; GAGCAAGAGCTT 10.20
g.1038C→T; g.2098T→C; g.2851T→C AGGTGGGCTCTC 3.20
GGATGGACGTCC 3.20
Xi'an g.-1431C→T; g.-741T→C; g.-498A→C; AGCACCCCGT 46.10
g.100G→A; g.2098T→C; g.2664T→C; GGCGTCCAGC 9.60
g.2851T→C; g.3385A→C; g.3791A→G; GGAGTCCAGC 9.20
g.4402C→T GACGTCTCAC 8.50
AGCACCCCGC 5.30
GGCGTTCAGC 4.80
AGCGCCCCGT 4.10
GGCATCCAGC 3.30
a The haplotypes composed of the tag SNPs selected in each population are shown.
Only haplotypes with a frequency greater than 3% are listed.
156 S. Qin et al. / Genomics 92 (2008) 152–158primary language. The differences in allele frequencies indicate that
genetic composition also varies between the different geographical
populations. Systematic analysis of the polymorphisms of this gene in
different Han subpopulations and a mapping of the polymorphismTable 5
Comparison of CYP2D6 allele frequencies in different ethnic groups
CYP2D6 allele A
Chinese
(n=400)
Korean [6]
(n=400)
Caucasian [8]
(n=589)
Freq. P valuea Freq. P valuea
⁎1 24.65 33.25 0.0001 36.4 b0.0001
⁎2 11.06 10.13 0.5691 32.4 b0.0001
⁎3 0 0 2.04
⁎4 0.14 0.25 0.3752 20.7 b0.0001
⁎5 4.66 6.13 0.1834 1.95 0.0007
⁎6 0 0 0.93
⁎7 0 0 0.08
⁎8 0 0 0
⁎9 0 0 1.78
⁎10 52.53 45 0.0027 1.53 b0.0001
⁎11 0 0 0
⁎12 0 0 0
⁎13 0 0 0
⁎14 1.33 0.5 0.0694 0
⁎15 0 0 0.08
⁎16 0 0 0.08
⁎17 0 0
⁎18 0 0
⁎21 0 0.25
⁎27 0 0.38
⁎35 0 0.13
⁎39 0 0.63
⁎41 3.34 1.88 0.0606
⁎47 0 0.13
Duplication 1.43 1.13 0.6527 1.93 0.3322
a The P value is for the comparison of the allele frequencies between the Chinese populadistribution over the whole Han population will be useful for
personalized medicine in the Chinese population.
In addition, we analyzed the LD pattern throughout the whole
gene for each geographical population separately. This is the ﬁrst
study of the genetic structure of the CYP2D6 gene in the Chinese Han
population and one of the few in any population. Also, the difference
in the LD structure made a different tag SNP selection for each
population. The haplotypes were constructed from the tag SNPs, so
there was a different haplotype structure and haplotype distribution
for each of the four geographical populations. The combined effects of
some decreased-function variants will result in inactive enzymes.
Different polymorphisms and their combinations may produce
markedly different results in terms of CYP2D6 activity. So tag SNP
detection and haplotype analysis would be helpful to identify the
metabolizer phenotype.
We also compared the frequencies of alleles and genotypes with
those of other ethnic populations. Compared with other Asian
populations, the frequencies of the alleles detected in our Han
population are similar to those in the Korean and Japanese popula-
tions, apart from a few variants that are absent from our population
[6,19]. However, the comparisonwith Caucasian and African American
populations showed signiﬁcant differences. The inactive alleles
CYP2D6⁎3, ⁎4, ⁎5, ⁎6, ⁎7, ⁎15, and ⁎16 were found in Caucasian
populations, whereas only alleles CYP2D6⁎4, ⁎5, and ⁎14 were
detected in our population. In addition, there were signiﬁcant
differences in the frequencies of some alleles. For instance, the
frequency of allele ⁎4 is 20.7% in Caucasians (Pb0.001), 13.8% in the
Spanish (Pb0.001), and 7.8% among African Americans (Pb0.001), but
0.14% in our own study [8,20]. Allele ⁎10 showed a high frequency, of
52.53%, in our population compared to Caucasians (1.53%, Pb0.001)
[8,21]. We found a much lower frequency, of 1–2%, of alleles with a
CYP2D6 duplication in our population compared with the Spanish
population (4.27%, P=0.0089) [22]. These results indicate signiﬁcant
differences in polymorphism distributions between Asian, America,
and European populations.llele frequency (%)
African American [28]
(n=154)
Japanese [7]
(n=206)
Spanish [22]
(n=105)
Freq. P valuea Freq. P valuea Freq. P valuea
34.7 0.0007 43 b0.0001 31 0.0626
26.9 b0.0001 12.3 0.4755 40.47 b0.0001
0.3 0.95
7.8 b0.0001 0.2 0.4491 13.8 b0.0001
6.2 0.2933 4.5 0.9916 3.33 0.4144
0.95
0
0
2.38
7.5 b0.0001 38.1 b0.0001 1.9 b0.0001
0
0.7 0.1480 0
0
14.6
0.2
0
1.9 0.1596 1 0.5466 4.27 0.0089
tion and other ethnic populations.
157S. Qin et al. / Genomics 92 (2008) 152–158In conclusion, in the present study we systematically screened the
polymorphisms of the whole CYP2D6 gene, as well as conducting
function prediction, LD pattern analysis, tag SNP selection, and
haplotype analysis, in four different geographical Han populations of
mainland China. These data can serve as a baseline for larger studies
on the mechanism and effects of CYP2D6 polymorphisms in Asian
populations. It should also provide important data for the advance of
personalized medicine.
Materials and methods
Subjects
The study subjects consisted of 400 healthy unrelated Chinese volunteers from four
geographical areas of the Chinese mainland: 100 subjects from Xi'an City, which lies in
the west of China; 100 subjects from Shanghai City, which lies in the east of China; 100
subjects from Shenyang City, which lies in the north of China; and 100 subjects from
Shantou City, which lies in the south of China. Each group of 100 subjects consisted of
50 males and 50 females between 18 and 53 years of age. The locations of four different
geographical populations are shown in Supplementary Fig. 1. All subjects were judged
to be in good health in terms of their medical history and after a physical examination.
All participants gave ethnic information about themselves, their parents, and their
grandparents, indicating that they were of the same origin. The four different
populations were frequency-matched to each other on age and sex. An explanation of
the study was given to the participating subjects and they gave the standard informed
consent, which was reviewed and approved by the Shanghai Ethical Committee of
Human Genetic Resources. All subjects were Han Chinese in origin.
Polymerase chain reaction condition and DNA sequencing
A systematic polymorphism screening was performed using direct sequencing and
long-PCRs. Genomic DNA was isolated from peripheral blood using the standard
procedure. The PCR primers were designed to amplify 2000 bp of the 5′ ﬂanking
regions, all exons, and all introns of the CYP2D6 gene. To ensure that the whole gene
was analyzed, the PCR ampliﬁcation regions overlapped one another. Primers used in
the study are shown in Supplementary Table 1. The PCRs were carried out on the Gene
Amp PCR System 9700 (Applied Biosystems, Foster City, CA, USA) in a total volume of 15
μl containing 10 ng of genomic DNA, 10 mM Tris–HCl (pH 8.3), 50 mM KCl, 1.5–3.0 mM
MgCl2, 200 mM dNTP, 1 mM each primer, and 0.25 U Taq DNA polymerase. The cycling
protocol consisted of denaturation at 95 °C for 1 min, followed by 30–35 cycles at 95 °C
for 30 s, 50–65 °C for 1 min, 72 °C for 1 min, and a ﬁnal extension at 72 °C for 10 min.
Preparation of DNA for sequencing included incubation of PCR products with 0.1 U of
shrimp alkaline phosphatase (Roche, Basel, Switzerland) and 0.5 U of exonuclease I
(New England Biolabs, Inc., Beverly, MA, USA) at 37 °C for 45 min, followed by heat
inactivation at 85 °C for 20 min. The PCR products were sequenced using an ABI Prism
BigDye Terminator Cycle Sequencing Kit, version 3.1 (Applied Biosystems), on an ABI
Prism 3100 sequencer. Speciﬁc primers were designed to detect deletion and
duplication of CYP2D6. The CYP2D6⁎5 allele was detected using long-PCR as described
by Hersberger et al. [23] and Ishiguro et al. [24]. The duplication of the CYP2D6 genewas
analyzed according to established methods [8,25].
Statistical analysis
All of the polymorphisms were named based on the nucleotide reference sequence
(AY545216) and the protein reference sequences (P10635). Allele and genotype
frequencies were calculated by the counting method. Comparisons of allele and
genotype frequencies among different geographic populations or between Chinese
population and other ethnic populations were done using χ2 tests or Fisher’s exact
tests with a signiﬁcance level set at 0.05. All statistical works were implemented with
scripts running on an SAS 9.1.3 platform. The output of the analysis was delivered
through the SAS Output Delivery System (version 7). Hardy-Weinberg equilibrium
calculations were performed using the Arlequin program (http://anthropologie.unige.
ch/arlequin). Linkage disequilibrium measures between each of two loci were derived
using Haploview (http://www.broad.mit.edu/mpg/haploview) [26]. Tag SNPs were
selected using the Haploview version of the Tagger program (http://www.broad.mit.
edu/mpg/haploview), which is an extension of the algorithm developed by Carlson et
al. [27]. An r2 of 0.8 was selected as a threshold for all analyses. Haplotypes were then
generated from the selected tag SNPs and the frequencies of haplotypes were analyzed
on the Haploview program.
Automated splice site analysis
The strengths of splice sites for the corresponding splicing mutations were
evaluated with the information theory-based analysis software as previously described
[18]. The corresponding individual information content (Ri in bits) of the polymorphism
sites was evaluated using Web-based software (https://splice.cmh.edu). Mutational
severity was inferred by comparison of the Ri values of the mutant sequence with the
normal sequence.Analysis of functional sequences in the promoter region
The transcription factor binding analysis of the polymorphisms in the 5′-UTR was
performed on the Web-based Tfsitescan software based on the transcription factor
binding sites database. The normal and mutant sequences were analyzed separately.
The inﬂuence of the polymorphisms was inferred by a comparison of the results of the
normal and the mutated sequences.
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